🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Lung Cancer Biomarkers and Screening

Recruitingn/aAges 50 Years - anyAllNYU Langone Health
NCT00301119 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
DISEASE CHARACTERISTICS: * Screening Cohort * At high- or low-risk for lung cancer * Smoking history ≥ 20 pack years\* * With or without workplace exposure to asbestos * NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older * Rule-Out Lung cancer group * Referred for evaluation of suspicious nodules with 1 of the following diagnoses: * Lung cancer * Nonmalignant nodules (control group) PATIENT CHARACTERISTICS: * Not pregnant * No prior malignancy except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY: * Not specified
💊

What it tests

  • Not listed
📍

Where

1 site
NYU Cancer Institute at New York University Medical Center
New York, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy